Regulation & law · 02/12/2022Updated: 10/17/2026 · 1 min read

DEA Provides Notice on Bulk Marihuana Manufacturer Application from Attitude Wellness

Summary

The Drug Enforcement Administration (DEA) has received an application from Attitude Wellness to manufacture marihuana in bulk, and will evaluate it in accordance with DEA regulations governing scientific and medical research

Original source language: Federal Register — Justice DepartmentOpen original release →

Add your company to Business Communicator

We monitor business sources and connect attention with companies, profiles and services available in Business Communicator.

Create a free company profile Explore businesses on Business Maps →

Create a free company profile →

Explore insights

Business insights →

Global Markets News Trade Regulation News Business Technology News Fintech for Business: Payments & Banking News Supply Chain News Central Bank Policy News

Related business signals

Regulation & law · 9/14/2026

Bulk Manufacturer of Controlled Substances Application: Cambrex High Point, Inc.

Cambrex High Point, Inc. has submitted an application to the U.S. government to be registered as a bulk manufacturer of controlled substances, a key step in the production and distribution of certain medications. The company is seeking to manufacture basic classes of controlled substances, as outlined in the accompanying SUPPLEMENTARY INFORMATION.

Read summary →

Regulation & law · 9/8/2026

AndersonBrecon, Inc DBA PCI Pharma Services Seeks Registration as Controlled Substance Importer

AndersonBrecon, Inc DBA PCI Pharma Services has submitted an application to the government to be registered as an importer of controlled substances, a move that could impact the pharmaceutical industry.

Read summary →

Regulation & law · 9/8/2026

Fresenius Kabi USA, LLC Seeks Registration as Controlled Substance Importer

Fresenius Kabi USA, LLC has submitted an application to the U.S. government to be registered as an importer of controlled substances, including basic classes of medications. The company aims to import these controlled substances for distribution in the United States.

Read summary →

Regulation & law · 9/8/2026

Fisher Clinical Services, Inc. Seeks Registration as Controlled Substance Importer

Fisher Clinical Services, Inc. has submitted an application to the U.S. government to be registered as an importer of controlled substances, a move that could potentially impact the pharmaceutical industry.

Read summary →

Regulation & law · 9/2/2026

Department of Justice to Reestablish Global Justice Information Sharing Initiative Advisory Committee

The Department of Justice plans to file a charter for the reestablishment of the Global Justice Information Sharing Initiative Advisory Committee (GAC), a federal advisory committee, to provide recommendations on national justice information and criminal intelligence sharing policy. The GAC will support improved public safety and coordination among federal, state, local, tribal, territorial, and other justice-interested partners.

Read summary →

Regulation & law · 9/2/2026

FBI to Submit Information Collection Request for Evaluation Data Collection

The Federal Bureau of Investigation (FBI), part of the Department of Justice (DOJ), is seeking OMB approval to extend a previously approved data collection, which involves collecting end-of-session questionnaires to evaluate the FBI's collecting capabilities.

Read summary →